Another group of patients gets left behind in Sarepta saga

Families with limb-girdle muscular dystrophy hoped for gene therapy but "overnight, it's gone."

August 21, 2025 Check out STAT+

Sponsored By

Shahrzad Rasekh for STAT STAT+ | As Sarepta Therapeutics fights for Duchenne therapy, a group of patients gets left behind After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without long-promised treatments. By Jason Mast CDC attacker likely attempted to enter campus days before shooting The man who attacked the CDC appears to have tried to enter the Atlanta campus days earlier, a security official told stafaf. By Daniel Payne STAT+ | Major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, FDA finds The Indiana plant, once owned by Catalent and now owned by Novo Nordisk, is widely used by the pharmaceutical industry. By Ed Silverman and Elaine Chen Adobe Brain map does not change following amputation, new study finds, upending assumptions New research shows brain maps remain intact after limb loss, reshaping ideas on phantom limb pain and opening doors for advanced neural prosthetics. By Veronica Paulus STAT+ | Gilead's Kite Pharma acquires Interius BioTherapeutics for $350 million The purchase by Kite is latest move in a race to develop simpler, safer, and more scalable cell therapies. By Jason Mast STAT+ | FDA approves Ionis drug that prevents swelling attacks caused by a rare disease Ionis faces stiff competition from Takeda, which markets the blockbuster Takhzyro, and the BioCryst Pharmaceuticals drug Orladeyo By Jonathan Wosen Viking's obesity flop, 'pharma to table' drug sales We discuss why direct-to-consumer plans championed by Eli Lilly, Novo Nordisk, and others are unlikely to make drugs more affordable. By Adam Feuerstein, Elaine Chen, and Allison DeAngelis Opinion: The trauma of illness can last long after the body has healed Medicine overlooks the psychological toll of medical illness. Healing must involve helping people repair their relationship with their bodies. By Alexandra Kutnick

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser